site stats

Ctic stock earnings

WebAug 1, 2024 · Get the latest CTI BioPharma Corp. (CTIC) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. ... Financials … WebApr 8, 2024 · CTI BioPharma last announced its earnings data on March 6th, 2024. The biopharmaceutical company reported ($0.14) earnings per share (EPS) for the quarter, …

CTIC Insider Trading Activity CTI BioPharma Insider Buys and Sells

WebStock Quote. Change Volume 52 Week High 52 Week Low Apr 13, 2024 1:41 PM EDT. Data Provided by Refinitiv. ... Wash. , April 12, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today … literary ethnography https://petersundpartner.com

CTIC - CTI Biopharma Corp Forecast - CNNMoney.com

WebOn Mar 06, 2024, Cti Biopharma ( NASDAQ: CTIC) reported Q4 2024 earnings per share (EPS) of -$0.12, up 69.23% year over year. Total Cti Biopharma earnings for the quarter were -$17.46 million. In the same quarter last year, Cti Biopharma 's earnings per share (EPS) was -$0.39. If you're new to stock investing, here's how to buy Cti Biopharma stock. WebMar 10, 2024 · CTIC: Get the latest CTI BioPharma stock price and detailed information including CTIC news, historical charts and realtime prices. ... Earnings Report-0.099 USD : Q1 2024 Earnings Release: 05/04 ... WebMar 17, 2024 · CTI BioPharma ( NASDAQ:CTIC – Get Rating) last issued its quarterly earnings data on Monday, March 6th. The biopharmaceutical company reported ($0.14) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.04). CTI BioPharma had a negative net margin of 172.37% and a negative return on … importance of section modulus

CTI BioPharma Corp. (CTIC) - Yahoo Finance

Category:CTIC Stock Price and Chart — NASDAQ:CTIC — TradingView

Tags:Ctic stock earnings

Ctic stock earnings

CTI BioPharma (NASDAQ:CTIC) Upgraded to “Hold” by …

WebApr 4, 2024 · The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of ... WebCTIC Stock Price - CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. ... The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the ...

Ctic stock earnings

Did you know?

WebMar 17, 2024 · CTI BioPharma Corp. analyst estimates, including CTIC earnings per share estimates and analyst recommendations. WebCTI BioPharma (CTIC) Reports Q4 Loss, Lags Revenue Estimates. CTI BioPharma (CTIC) delivered earnings and revenue surprises of -55.56% and 15.24%, respectively, for the quarter ended December 2024 ...

WebApr 7, 2024 · CTI BioPharma Corp’s trailing 12-month revenue is $53.9 million with a -172.4% profit margin. Year-over-year quarterly sales growth most recently was %. … Web1 day ago · CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies …

Web2 days ago · Get the latest CTI BioPharma Corp CTIC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ... In fact, when combining a Zacks Rank #3 or … Web1 day ago · • Regarding CTIC CTIC, we observe a call option trade with bullish sentiment. It expires in 65 day(s) on June 16, 2024 . Parties traded 3000 contract(s) at a $5.00 strike.

WebApr 13, 2024 · As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.1, which is expected to increase to -$0.08 for fiscal year -$0.43 and then to about -$0.29 by fiscal year 2024.

WebApr 11, 2024 · CTI BioPharma (CTIC) In a report released yesterday, Robert Hazlett from BTIG maintained a Buy rating on CTI BioPharma, with a price target of $9.00. The company’s shares closed last Monday at ... literary evaluationWebStock Price Forecast. The 9 analysts offering 12-month price forecasts for CTI Biopharma Corp have a median target of 10.00, with a high estimate of 15.00 and a low estimate of … importance of secure attachmentWebMar 6, 2024 · The "days to cover" for this stock exceeds 18 days. ... Zacks Investment Research reports that the 2024 Price to Earnings ratio for CTIC is -7.47 vs. an industry … importance of secure softwareWebApr 9, 2024 · 6 brokers have issued 12 month price targets for CTI BioPharma's shares. Their CTIC share price forecasts range from $9.00 … importance of security in hotelWebStock is heavily short : 20% of float is short 80% Institutional investors. nice swing opportunity for a re-bounce to the upper "resistance" channel line. NASDAQ:CTIC Stock … importance of security servicesWebApr 10, 2024 · CTI BioPharma (CTIC) delivered earnings and revenue surprises of -55.56% and 15.24%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? 1 month ago - Zacks Investment Research importance of security awarenessWebApr 10, 2024 · The equity awards were approved on April 10, 2024, in accordance with Nasdaq Listing Rule 5635 (c) (4). The employees received options to purchase an … importance of sedimentation